Cargando…
Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial
INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure and with an average life expectancy of 3–5 years post diagnosis. The use of complementary medicine such as medicinal cannabis in search for a potential treatment or cure is common in ALS. Preclinical...
Autores principales: | Urbi, Berzenn, Broadley, Simon, Bedlack, Richard, Russo, Ethan, Sabet, Arman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858175/ https://www.ncbi.nlm.nih.gov/pubmed/31719072 http://dx.doi.org/10.1136/bmjopen-2019-029449 |
Ejemplares similares
-
Effects of cannabinoids in Parkinson’s disease animal models: a systematic review and meta-analysis
por: Urbi, Berzenn, et al.
Publicado: (2022) -
Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease
por: Mukherjee, Nisha, et al.
Publicado: (2017) -
The emerald city: the future of CERN
Publicado: (2004) -
GPU Computing Gems Emerald Edition
por: Hwu, Wen-mei W
Publicado: (2011) -
EMERALD—Exercise Monitoring Emotional Assistant
por: Rincon, Jaime A., et al.
Publicado: (2019)